Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1100.60 -32.80 (-2.89%)

50.01% Gain from 52W Low

49,771 NSE+BSE Volume

NSE 21 Mar, 2025 3:31 PM (IST)

13,486.4

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Alivus Life Sciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alivus Life Sciences Ltd. from all sources in a single place.

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

120 Votes:

Buy 75.0%

Sell 13.33%

Hold 11.67%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >